Literature DB >> 26424258

The Structure of Natural and Recombinant Antibodies.

Hui Ma1, Richard O'Kennedy2.   

Abstract

Immunoglobulins (Ig) isotypes A, D, E, G, and M are glycoproteins which are mainly composed of a "Y"-shaped Ig monomer (~150 kDa), consisting of two light and two heavy chains. Both light and heavy chains contain variable (N-terminal) and constant regions (C-terminal). Each light chain consists of one variable domain and one constant domain, whereas each heavy chain has one variable domain and three constant domains. However, heavy-chain antibodies consisting of only heavy chains and lacking the light chains are found in camelids and cartilaginous fishes. Unlike other immunoglobulins, the heavy chain of avian antibody IgY (~180 kDa) consists of four constant domains. The single-chain variable fragment (scFv; ~25 kDa) of an antibody contains variable regions of antibody heavy and light chains. The fragment antigen-binding (Fab; ~50 kDa) region has the full antibody light chain but the heavy chain is composed of a variable region and one constant domain.

Entities:  

Keywords:  Fab; IgG; IgY; ScFv

Mesh:

Substances:

Year:  2015        PMID: 26424258     DOI: 10.1007/978-1-4939-2999-3_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

Review 2.  Peptides, Antibodies, Peptide Antibodies and More.

Authors:  Nicole Trier; Paul Hansen; Gunnar Houen
Journal:  Int J Mol Sci       Date:  2019-12-13       Impact factor: 5.923

Review 3.  Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.

Authors:  Shuyang Sun; Ziqiang Ding; Xiaomei Yang; Xinyue Zhao; Minlong Zhao; Li Gao; Qu Chen; Shenxia Xie; Aiqun Liu; Shihua Yin; Zhiping Xu; Xiaoling Lu
Journal:  Int J Nanomedicine       Date:  2021-03-22

Review 4.  Nucleic Acids Analytical Methods for Viral Infection Diagnosis: State-of-the-Art and Future Perspectives.

Authors:  Emanuele Luigi Sciuto; Antonio Alessio Leonardi; Giovanna Calabrese; Giovanna De Luca; Maria Anna Coniglio; Alessia Irrera; Sabrina Conoci
Journal:  Biomolecules       Date:  2021-10-27

5.  Production and Evaluation of Chicken Egg Yolk Immunoglobulin (IgY) against Human and Simian Rotaviruses.

Authors:  Gentil Arthur Bentes; Natália Maria Lanzarini; Juliana Rodrigues Guimarães; Marcos Bryan Heinemann; Eduardo de Mello Volotão; Alexandre Dos Santos da Silva; Luiz Guilherme Dias Heneine; Jaqueline Mendes de Oliveira; Marcelo Alves Pinto
Journal:  Viruses       Date:  2022-09-09       Impact factor: 5.818

6.  Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.

Authors:  Navasona Krishnan; Christopher A Bonham; Ioana A Rus; Om Kumar Shrestha; Carla M Gauss; Aftabul Haque; Ante Tocilj; Leemor Joshua-Tor; Nicholas K Tonks
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

7.  Granulocyte-macrophage colony stimulating factor (GM-CSF) is fully expressed in the genital tract, seminal plasma and spermatozoa of male pigs.

Authors:  Lorena Padilla; Jesús Martínez-Hernández; Isabel Barranco; Xiomara Lucas; Luis M Pastor; Heriberto Rodriguez-Martínez; Jordi Roca; Inmaculada Parrilla
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

Review 8.  Improving Immunotherapy Through Glycodesign.

Authors:  Matthew J Buettner; Sagar R Shah; Christopher T Saeui; Ryan Ariss; Kevin J Yarema
Journal:  Front Immunol       Date:  2018-11-02       Impact factor: 7.561

Review 9.  The role of antibody-based troponin detection in cardiovascular disease: A critical assessment.

Authors:  Hui Ma; Arabelle Cassedy; Richard O'Kennedy
Journal:  J Immunol Methods       Date:  2021-07-28       Impact factor: 2.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.